Transfusion Medicine Reviews
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Proceedings of a Consensus Conference: Towards an Understanding of TRALI
2005
-
Optimizing Informed Consent Discussions: Developing a Narrative for Transfusion Consent.
150757-150757.
2023
-
Reflections of Dr. Morris Blajchman (1940-2022).
36:115-116.
2022
-
Anemia-Induced Bleeding in Patients with Platelet Disorders.
35:22-28.
2021
-
Cold-stored leukoreduced whole blood: no impact of extended time between donation and filtration on in vitro quality.
35:56-56.
2021
-
Efficacy and Safety of Tranexamic Acid in Major Non-Cardiac Surgeries at High Risk for Transfusion: A Systematic Review and Meta-Analysis.
34:51-62.
2020
-
Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration.
33:78-83.
2019
-
Exploring donor and product factors and their impact on red cell post-transfusion outcomes.
32:28-35.
2018
-
Intersecting Worlds of Transfusion and Transplantation Medicine: An International Symposium Organized by the Canadian Blood Services Centre for Innovation.
31:183-192.
2017
-
Selection and Characterization of a DNA Aptamer Inhibiting Coagulation Factor XIa.
30:146-147.
2016
-
Understanding intravenous iron ordering practices for inpatients and outpatients at a large academic institution.
30:147-147.
2016
-
Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.
30:53-68.
2016
-
Design and Implementation of a Competency-Based Transfusion Medicine Training Program in Canada.
30:30-36.
2016
-
Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized Trial.
30:25-29.
2016
-
Plasma and Plasma Protein Product Transfusion: A Canadian Blood Services Centre for Innovation Symposium.
29:181-194.
2015
-
Transfusion Medicine in Sub-Saharan Africa: Conference Summary.
29:195-204.
2015
-
Platelet Utilization: A Canadian Blood Services Research and Development Symposium.
28:84-97.
2014
-
Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia.
27:137-145.
2013
-
Benchmarking: Applications to Transfusion Medicine.
26:321-332.
2012
-
The PRECISE RCT: Evolution of an Early Septic Shock Fluid Resuscitation Trial.
26:333-341.
2012
-
Proceedings of a Consensus Conference: Risk-Based Decision Making for Blood Safety.
25:267-292.
2011
-
The Age of Blood Evaluation (ABLE) Randomized Controlled Trial: Study Design.
25:197-205.
2011
-
Transfusion-Associated Hyperkalemia.
25:184-196.
2011
-
Cerebral Venous Thrombosis During Pregnancy in the Setting of Type I Antithrombin Deficiency: Case Report and Literature Review.
25:61-65.
2011
-
Clinical Trial Opportunities in Transfusion Medicine: Proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium.
24:259-285.
2010
-
Blood Still Kills: Six Strategies to Further Reduce Allogeneic Blood Transfusion-Related Mortality.
24:77-124.
2010
-
Extending the Horizon for Cell-Based Immunotherapy by Understanding the Mechanisms of Action of Photopheresis.
24:22-32.
2010
-
The Use of Immunoglobulin Therapy for Patients Undergoing Solid Organ Transplantation: An Evidence-Based Practice Guideline.
24:S7-S27.
2010
-
Severe Hemolytic Anemia Post–Renal Transplantation Produced by Donor Anti-D Passenger Lymphocytes: Case Report and Literature Review.
23:155-159.
2009
-
The Age of Red Blood Cells in Premature Infants (ARIPI) Randomized Controlled Trial: Study Design.
23:55-61.
2009
-
Diagnosis and Management of Neonatal Alloimmune Thrombocytopenia.
22:255-267.
2008
-
Proceedings of a Consensus Conference: Pathogen Inactivation—Making Decisions About New Technologies.
22:1-34.
2008
-
Evidence-Based Guidelines on the Use of Intravenous Immune Globulin for Hematologic and Neurologic Conditions.
21:S3-S8.
2007
-
Guidelines on the Use of Intravenous Immune Globulin for Hematologic Conditions.
21:S9-S56.
2007
-
Guidelines on the Use of Intravenous Immune Globulin for Neurologic Conditions.
21:S57-S107.
2007
-
Anticoagulants and Their Reversal.
21:37-48.
2007
-
Testing for Heparin-Induced Thrombocytopenia Antibodies.
20:259-272.
2006
-
Bacterial Detection of Platelets: Current Problems and Possible Resolutions.
19:259-272.
2005
-
Blood Group Biochemistry: A Canadian Blood Services Research and Development Symposium.
19:295-307.
2005
-
Transfusion Medicine in the Era of Genomics and Proteomics.
19:288-294.
2005
-
Coagulation Disorders and Blood Product Use in Patients Undergoing Thoracoabdominal Aortic Aneurysm Repair.
19:143-154.
2005
-
Protecting the Blood Supply From Emerging Pathogens: The Role of Pathogen Inactivation.
19:110-126.
2005
-
Bloody easy: blood transfusions, blood alternatives and transfusion reactions. A guide to transfusion medicine. (Web site: www.sunnybrookandwomens.on.ca)Edited by Callum JL, Pinkerton PH. Sunnybrook & Women’s College Health Sciences Centre, Toronto, ON, 2003.
18:233-234.
2004
-
Proceedings of a consensus conference: the screening of blood donors for variant CJD1 1This Consensus Conference took place at the Ritz Carlton Hotel in Montreal, Quebec, on March 26–28, 2003, and was chaired by Dr. Gilles Delage of Héma Québec..
18:73-92.
2004
-
Improving the bacteriological safety of platelet transfusions.
18:11-24.
2004
-
Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome.
17:272-286.
2003
-
Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome.
17:272-286.
2003
-
Transfusion-related acute lung injury.
17:252-262.
2003
-
The application of the precautionary principle to the blood system: The Canadian blood system's vCJD donor deferral policy.
17:89-94.
2003
-
Proceedings of a consensus conference: Blood-borne HIV and hepatitis—Optimizing the donor selection process†.
17:1-30.
2003
-
A review of randomized controlled trials using therapeutic apheresis*.
16:200-229.
2002
-
Genetically modified dendritic cells in cancer therapy: Implications for transfusion medicine.
15:292-304.
2001
-
Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference*.
15:108-135.
2001
-
Proceedings of a Consensus Conference: Prevention of Post-Transfusion CMV in the Era of Universal Leukoreduction1.
15:1-20.
2001
-
Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion.
14:23-33.
2000
-
Novel platelet products and substitutes.
12:175-187.
1998
-
The alloimmune thrombocytopenic syndromes.
11:296-307.
1997
-
A proposal for an individual patient data based meta-analysis of randomized controlled trials of allogeneic transfusion and postoperative bacterial infection.
11:180-194.
1997
-
Concepts and techniques in molecular biology—An overview*.
11:209-223.
1997
-
The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes.
11:95-105.
1997
-
The use of allogeneic leukocytes or IV IgG for the treatment of patients with recurrent spontaneous abortions*.
11:85-94.
1997
-
Coagulation factor concentrates by continuous infusion.
11:56-63.
1997
-
Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia.
10:249-258.
1996
-
Noninfectious adverse effects of blood transfusion in the neonate..
9:277-287.
1995
-
The Impact of New Clinical Guidelines on the North American Blood Economy.
8:232-241.
1994
-
Understanding the Polymerase Chain Reaction.
8:242-252.
1994
-
Hemolytic and Pseudo-Hemolytic Transfusion Reactions: An Overview of the Hemolytic Transfusion Reactions and the Clinical Conditions That Mimic Them.
8:184-199.
1994
-
Hepatitis C Infection in Patients With Hemophilia: Results of a National Survey.
8:210-217.
1994
-
Canadian Red Cross Society Symposium on Leukodepletion: Report of Proceedings.
8:1-14.
1994
-
The Efficacy of Leukodepletion to Improve Platelet Transfusion Response: A Critical Appraisal of Clinical Studies.
8:15-28.
1994
-
The Risk of Varicella-Zoster Infections in Different Patient Populations: A Critical Review.
8:96-116.
1994
-
Forensic Identity Testing Using Highly Polymorphic DNA Markers: Current Status and Emerging Technologies.
7:193-205.
1993
-
Monoclonal Antibodies Against Platelet Glycoproteins.
7:156-172.
1993
-
Vertical Transmission of Viral Hepatitis.
7:112-120.
1993
-
Summary of Panel Discussion, First Day.
6:263-264.
1992
-
DDAVP—The Multipotent Drug in Patients With Coagulopathies.
5:132-144.
1991
-
Blood Product-Associated Bacterial Sepsis.
5:73-83.
1991
-
Current Controversies Concerning the Measurement of Platelet-Associated IgG.
4:121-135.
1990
-
Platelet Immunobiology.
4:85-86.
1990
-
The Molecular Pathology of Inherited Human Antithrombin III Deficiency.
3:264-281.
1989
-
Acute Paroxysmal Cold Hemoglobinuria.
3:219-229.
1989
-
The Role of Red Blood Cell Antigens, Histocompatibility Antigens, and Blood Transfusions on Renal Allograft Survival.
3:171-179.
1989
-
Use of Intravenous Gammaglobulin as an Immune Replacement and an Immune Suppressant.
3:82-120.
1989
-
Platelet and Red Cell Clearance Is Determined by the Interaction of the IgG and Complement on the Cells and the Activity of the Reticuloendothelial System.
1:75-84.
1987
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)